Viewing Study NCT07332260


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-31 @ 1:20 PM
Study NCT ID: NCT07332260
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-01-14
First Post: 2025-11-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study
Sponsor: University Hospital of North Norway
Organization:

Study Overview

Official Title: Alzheimer's Disease and Faecal Microbiota Transplantation
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: AD-FMT
Brief Summary: The goal of this study is to assess the feasibility and safety of faecal microbiota transplantation for Alzheimer's disease.
Detailed Description: Alzheimer's disease (AD) is the most common cause of dementia.

Studies suggest that the gut flora may play a role in the development and/or progression of AD. The gut flora is found to be different in AD compared to healthy individuals. There is also support for a link between the gut flora and diseases affecting the brain, including AD.

Stool transplantation is an established medical treatment for Clostridioides difficile infections by restoring the balance of the gut flora. In this study, gut flora (a stool solution) is transferred from a healthy individual to an individual with AD. The stool transplantation is given during a colonoscopy examination of the large bowel.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: